Convergence Investment Partners’s Usana Health Sciences USNA Stock Holding History

Convergence Investment Partners’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,687	Closed	-$141K	–	390
2019 Q1	$141K	Sell	1,687 -483	-22%	-$50.4K	0.03%	299
2018 Q4	$255K	Sell	2,170 -949	-30%	-$110K	0.06%	274
2018 Q3	$376K	Buy	+3,119	New	+$387K	0.08%	250
2015 Q4	–	Sell	-44,428	Closed	-$2.98M	–	389
2015 Q3	$2.98M	Buy	+44,428	New	+$3.14M	0.34%	108
2015 Q2	–	Sell	-14,146	Closed	-$786K	–	421
2015 Q1	$786K	Buy	+14,146	New	+$725K	0.11%	287

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Convergence Investment Partners's USNA Position: Q2 2019 in Review

Convergence Investment Partners sold out of Usana Health Sciences (USNA) in Q2 2019, closing a stake of 1,687 shares — an estimated $141K sold.

Convergence Investment Partners first reported a position in USNA in Q1 2015 and held it in 5 quarters. The position peaked at $2.98M in Q3 2015. 173 funds tracked by Wall St. Rank hold USNA as of Q2 2019.

Convergence Investment Partners reported no remaining Usana Health Sciences position as of Q2 2019 after selling out during the quarter.
Convergence Investment Partners sold 1,687 Usana Health Sciences shares in Q2 2019, an estimated $141K.
Convergence Investment Partners first reported a position in Usana Health Sciences in Q1 2015 and held it in 5 quarters.
Convergence Investment Partners's Usana Health Sciences position peaked at $2.98M in Q3 2015.
173 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2019.

Based on Convergence Investment Partners's 13F filing for Q2 2019, filed 23 Jul 2019.